GLP-1 weight-loss drugs are popular but pricey. New data highlights use by age and gender - and why interest outpaces access for many.

Britain's pharmacy regulator warned it had been forced to step in, to 'investigate concerns' that prescription drugs had been ...

Corcept's Q2 2025 saw 60% therapy demand growth despite bottlenecks. Despite near-term operational risks, we maintain ...

Thanks to a series of equity and debt offerings, Insulet has managed to buy time in the race to expand its sales base and reach profitability before running out of cash. As of the end of December, ...

This episode of Pharma Pulse examines how in-store pharmacies are evolving beyond prescriptions to deliver clinical services, ...

O'Reilly Automotive Inc. is suing the three major pharmacy benefit managers in the U.S., as well as the three major insulin manufacturers.

Q2 2025 Management View John F. Sheridan, President and CEO, highlighted record second quarter sales in the U.S. and ...

CVS Caremark owes the State of West Virginia $1.4 million in civil penalties after the state’s insurance commissioner found it violated state code. The $1.4 million fine is based on 2,871 violations, ...

Danish drugmaker Novo Nordisk said on Tuesday it has filed 14 new lawsuits in the United States against the sale of ...

Despite being home to one of the world largest medicine markets, millions of Indian families continue to struggle with the ...

Hundreds of pharmacies across Pennsylvania have gone out of business in recent years, data obtained by Spotlight PA shows, ...

The Congressional Budget Office forecasts that the U.S. uninsured population will grow by 10 million in 2034, due to the tax ...